PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Mayo Clinic, Rochester, Minnesota, USA.\', \'Mayo Clinic Health System, Eau Claire, Wisconsin, USA.\', \'Mayo Clinic Health System, Mankato, Minnesota, USA.\', \'Mayo Clinic Health System, Lake City, Minnesota, USA.\', \'Mayo Clinic Arizona, Phoenix, Arizona, USA.\', \'Mayo Clinic, Jacksonville, Florida, USA.\', \'Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/infdis/jiab377
?:hasPublicationType
?:journal
  • The Journal of infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34279629
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34279629>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34279629>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all